查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386270

神經生物標記物市場報告：2030 年趨勢、預測與競爭分析

Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

神經生物標記的趨勢和預測

到 2030 年，全球神經生物標記市場預計將達到 147 億美元，2024 年至 2030 年年複合成長率為 11.7%。該市場的主要驅動力是液體活體組織切片的日益普及、人工智慧 (AI) 在神經生物標記開發中的使用增加以及個人化醫療需求的不斷成長。全球神經生物標記市場的未來充滿希望，醫院/醫院實驗室、獨立臨床診斷中心和研究機構市場都有機會。

神經生物標記市場洞察

Lucintel 預測，由於神經系統疾病的盛行率不斷增加，蛋白質體學將在預測期內達到最高成長。

在這個市場中，醫院和醫院實驗室將見證最高的成長，因為它們被認為是神經系統疾病診斷服務的主要提供者。

由於阿茲海默症、帕金森氏症和多發性硬化症等神經系統疾病的高盛行率，以及該地區醫療保健支出的增加，預計北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球神經生物標記市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球神經生物標記市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球神經生物標記市場
    • 基因組
    • 蛋白質體學
    • 代謝組學
    • 影像
    • 其他
  • 全球神經生物標記市場（按應用）
    • 阿茲海默症
    • 帕金森氏症
    • 多發性硬化症
    • 泛自閉症障礙
    • 其他
  • 按最終用途分類的全球神經生物標記市場
    • 醫院和醫院實驗室
    • 獨立臨床診斷中心
    • 研究機構等

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球神經生物標記市場（按地區）
  • 北美神經生物標記市場
  • 歐洲神經生物標記市場
  • 亞太神經生物標記市場
  • 其他區域神經生物標記市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球神經生物標記市場成長機會
    • 全球神經生物標記物市場成長機會（按應用）
    • 全球神經生物標記物市場成長機會（依最終用途）
    • 按地區分類的全球神經生物標記市場成長機會
  • 全球神經生物標記市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球神經生物標記市場的產能擴張
    • 全球神經生物標記市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • BANYAN BIOMARKERS
  • Myriad Genetics
簡介目錄

Neurological Biomarker Trends and Forecast

The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Neurological Biomarker by Segment

The study includes a forecast for the global neurological biomarker by type, application, end use, and region.

Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Genomic
  • Proteomic
  • Metabolomic
  • Imaging
  • Others

Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Alzheimer'S Disease
  • Parkinson'S Disease
  • Multiple Sclerosis
  • Autism Spectrum Disorder
  • Others

Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital & Hospital Laboratories
  • Independent Clinical Diagnostic Centers
  • Research Organizations and Others

Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neurological Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • Banyan Biomarkers
  • Myriad Genetics

Neurological Biomarker Market Insights

Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.

North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Features of the Global Neurological Biomarker Market

Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the neurological biomarker market size?

Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.

Q.2 What is the growth forecast for neurological biomarker market?

Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the neurological biomarker market?

Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

Q4. What are the major segments for neurological biomarker market?

Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.

Q5. Who are the key neurological biomarker market companies?

Answer: Some of the key neurological biomarker companies are as follows:

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • Banyan Biomarkers
  • Myriad Genetics

Q6. Which neurological biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neurological biomarker market by type (genomic, proteomic, metabolomic, imaging, and others), application (alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder, and others), end use (hospital & hospital laboratories, independent clinical diagnostic centers, and research organizations and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurological Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neurological Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neurological Biomarker Market by Type
    • 3.3.1: Genomic
    • 3.3.2: Proteomic
    • 3.3.3: Metabolomic
    • 3.3.4: Imaging
    • 3.3.5: Others
  • 3.4: Global Neurological Biomarker Market by Application
    • 3.4.1: Alzheimer's Disease
    • 3.4.2: Parkinson's Disease
    • 3.4.3: Multiple Sclerosis
    • 3.4.4: Autism Spectrum Disorder
    • 3.4.5: Others
  • 3.5: Global Neurological Biomarker Market by End Use
    • 3.5.1: Hospital & Hospital Laboratories
    • 3.5.2: Independent Clinical Diagnostic Centers
    • 3.5.3: Research Organizations and Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neurological Biomarker Market by Region
  • 4.2: North American Neurological Biomarker Market
    • 4.2.2: North American Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.3: European Neurological Biomarker Market
    • 4.3.1: European Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.3.2: European Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.4: APAC Neurological Biomarker Market
    • 4.4.1: APAC Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.4.2: APAC Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.5: ROW Neurological Biomarker Market
    • 4.5.1: ROW Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.5.2: ROW Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neurological Biomarker Market by Type
    • 6.1.2: Growth Opportunities for the Global Neurological Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Neurological Biomarker Market by End Use
    • 6.1.4: Growth Opportunities for the Global Neurological Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Neurological Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neurological Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurological Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Thermo Fisher Scientific
  • 7.3: Bio-Rad Laboratories
  • 7.4: Merck
  • 7.5: Johnson & Johnson Services
  • 7.6: BANYAN BIOMARKERS
  • 7.7: Myriad Genetics